Browsing Tag

Bharat Biotech

Bharat Biotech’s COVID Vaccine Could Be Launched In Feb 2021: ICMR

indbadmin Nov 5, 2020

New Delhi: With last-stage trials beginning this month, the Indian government-backed COVID-19 vaccine could be launched in February. Since studies so far show that it is safe and effective, it could come months earlier than expected…

Bharat Biotech’s COVID-19 Vaccine To Launch In Q2 of Next Year

indbadmin Nov 1, 2020

Hyderabad: Bharat Biotech's vaccine Covaxin is expected to be launched in Q2 of 2021 pending approvals from authorities. The phase 3 trials will be started at the earliest across the nation, according to reports. Covaxin has been…

Covaxin To Have At Least 60% Efficacy, Says Bharat Biotech

indbadmin Oct 23, 2020

New Delhi: Covaxin, India's first indigenous COVID-19 vaccine candidate, developed by Bharat Biotech is expected to have at least 60 per cent effectiveness, Hindustan Times (HT) reported. The Drugs Controller General of India (DCGI) on…

COVID-19 Vaccine: DCGI Gives Its Nod To Bharat Biotech’s Covaxin For Phase 3 Trial

indbadmin Oct 23, 2020

New Delhi: The Bharat Biotech developed-vaccine in collaboration with the Indian Council of Medical Research (ICMR) — Covaxin — has got the approval for the third phase of clinical trials. The Hyderabad-based vaccine maker on October 2 had…

Bharat Biotech, Serum Institute To Start Trial Of Late-Stage Intranasal COVID-19 Vaccine Soon

indbadmin Oct 19, 2020

New Delhi: Union Health Minister Harsh Vardhan said that late-stage clinical trials of intranasal COVID-19 vaccines are expected to be pursued by Serum Institute of India and Bharat Biotech once they receive regulatory approval. The…

Covaxin To Use ViroVax’s Adjuvant To Boost Immunity

indbadmin Oct 5, 2020

New Delhi: Covaxin, India's first indigenous COVID vaccine, will use adjuvant Alhydroxiquim-II to increase immune response, informed Bharat Biotech on Monday. ViroVax LLC, a Kansas based company, has licensed their adjuvant for the use of…

Bharat Biotech Collaborates With Washington-Based University For Intranasal COVID Vaccine

indbadmin Sep 23, 2020

Hyderabad: India's vaccine maker Bharat Biotech is collaborating with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single-dose intranasal vaccine for COVID-19. The Hyderabad-based company owns the…

COVID-19 Vaccine In India To Be Available By Start Of 2021: Health Minister

indbadmin Sep 17, 2020

New Delhi: A coronavirus vaccine will be available in the country by the beginning of next year, Union Health Minister Harsh Vardhan told the Rajya Sabha on Thursday. “Just like other countries, India is also making efforts. Three vaccines…

COVID-19 Vaccine Trials: Covaxin Found Effective In Non-Human Primates

indbadmin Sep 12, 2020

New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has demonstrated protective efficacy and immunogenicity in non-human primates in Phase I clinical trials in India. Covaxin, which is developed by Bharat Biotech and ICMR, is…

Phase II Trials Of Covaxin To Begin Tomorrow: Report

indbadmin Sep 6, 2020

New Delhi: Phase II trials of the indigenously developed COVID-19 vaccine, Covaxin, is likely to begin on Monday, according to a media report on Sunday. Covaxin has been developed by Hyderabad-based Bharat Biotech in collaboration with…

Older Posts

Newer Posts